首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 109 毫秒
1.
Objective: This study was aimed at evaluating and comparing the quality of life in patients who underwent laparo-scopic and open cholecystectomy for chronic cholecystolithiasis. Methods: The study included 25 patients with laparoscopic cholecystectomy (LC group) and 26 with open cholecystectomy (OC group). The quality of life was measured with the Gastrointestinal Quality of Life Index (GLQI) preoperatively, thereafter regularly at 2, 5, 10 and 16 weeks after the operation. Results: The mean preoperative overall GLQI scores were 112.5 and 110.3 in LC and OC group respectively (P>0.05). In the LC group, the mean overall GLQI score reduced slightly to 110.0 two weeks after the operation (P>0.05). The LC group showed significant improvement in overall score and in the aspects of symptomatology, emotional and physiological status from 5 to 16 weeks postoperatively. In the OC group, the GLQI score reduced to 102.0 two weeks after surgery (P<0.05). Significant reductions were shown in the aspects of symptomatology, physiological and social status. The GLQI scores returned to the preoperative level of 115.6 ten weeks after the operation (P>0.05). The patients experienced significant improvements of GLQI sixteen weeks after OC operation (P<0.01-0.05). Within the 10 postoperative weeks, the LC group had significantly higher GLQI scores than the OC group (P<0.05). Conclusions: LC can improve the quality of life postoperatively better and more rapidly than OC. The assessment of quality of life assessment is a valid method for measuring the effects of surgical treatment.  相似文献   

2.
目的:探讨腹腔镜胆囊切除术与开放胆囊切除术治疗胆囊结石的临床疗效。方法:选择2010年1月至2013年7月收治的胆囊结石患者共90例作为研究对象,按照治疗方式将其分为腹腔镜胆囊切除术(LC)组和开腹胆囊切除术(OC)组,比较两组患者疗效。结果:LC组手术时间、术中出血量、抗生素使用时间、胃肠功能恢复时间以及住院时间等围手术期指标均明显优于OC组(P〈0.05);LC组并发症发生率为0.1%,OC组并发症的发生率3%,LC组并发症的发生率明显低于OC组(P〈0.05)。结论:腹腔镜胆囊切除术治疗胆囊结石术中出血少,术后恢复快,住院时间短,是一种安全可靠的治疗方式。  相似文献   

3.
目的观察各种剂量右关托咪定超前镇痛用于腹腔镜胆囊切除手术的术后镇痛效果。方法60例择期行腹腔镜胆囊切除术的患者(均选取女性),年龄20—59岁,ASAI一Ⅱ,随机均分成四组:C组,D1组,D2组,D3组。c组为对照组,静脉注射安慰剂。D1组静注右美托咪定0.5μg/kg,D1组静注右美托咪定1.0μg/kg,D1组静注右美托咪定1.5μg/kg(四组注射时间均为切皮前10min)。记录术毕拔管时间、各时间点的vAs评分、Ramsay评分,同时观察不良反应发生几率。结果D2组、D3组拔管时间均长于c组,D3组的拔管时间长于D1组、D2组(P〈0.05);D2组、D3组在术毕各个时点的VAS均低于c组,D3组在术毕各个时点、D2组在术毕4h、8h的VAS均低于D1组(P〈0.05);D3组在术毕1、2、4h的Ramsay评分高于其余三组,D2组在术毕1h的Ramsay高于c组、D1组(P〈0.05);D3组术毕口干的发生率高于c组,c组术毕使用镇痛药的发生率高于其余三组(P〈0.05);结论术前静注右关托咪定1.0μg/kg,术毕镇痛可靠,不增加不良反应,不导致苏醒延迟。  相似文献   

4.
腹腔镜阑尾切除术与传统阑尾切除术疗效对比   总被引:2,自引:0,他引:2  
目的:比较腹腔镜阑尾切除术(laparoscopic appendectomy,LA)与传统剖腹阑尾切除术(open appendectomy,OA)的临床疗效。方法:将156例阑尾炎病例随机分成两组,一组72例行LA,另一组84例行OA,比较两种术式的手术时间、平均住院费用、住院时间,切口长度、术后镇痛剂应用、术后6h开始下床活动、术后24h内肛门排气例数、放置引流管率、切口感染等指标。结果:LA组的术后24h内肛门排气时间、放置引流管率、切口感染、平均住院时间、切口长度、粘连性肠梗阻、镇痛剂应用例数、术后6h开始下床活动例数与OA组比较,差异均有统计学意义(P<0.05);而两组手术时间比较差异无统计学意义(P>0.05);LA组住院费用较OA组明显增高(P<0.05)。结论:LA与OA比较,有手术损伤小、疼痛轻、恢复快、住院时间短、并发症少等优点,可作为大多数阑尾炎的首选手术方式。  相似文献   

5.
降低腹腔镜胆囊切除术并发症的对策   总被引:1,自引:0,他引:1  
结合病例,探讨降低腹腔镜胆囊切除术(LC)并发症的对策。指出LC手术初期必须加强基本功训练;严格选择病例及适应症;精心操作,处理好胆囊动脉及胆囊管;遇到困难及时中转开腹手术;术后严密观察并及时处理。  相似文献   

6.
目的分析分化型甲状腺癌术后~(131)I治疗患者应用协同模式对其心理状况及生活质量的影响。方法选取2018年10月~2020年10月在我院收治的甲状腺癌术后~(131)I治疗患者100例,采用随机数字表法将其分为两组,各50例。对照组患者采用常规模式干预,研究组采用协同护理模式,比较两组情绪、生活质量等改善情况。结果研究组干预后SAS评分,SDS评分,与对照组各评分比较差异明显(P<0.05)。干预后两组患者的自我效能评分均提升,且研究组干预后自我效能评分改善情况优于对照组(P<0.05)。两组干预后自护能力均较干预前改善,且研究组干预后自护能力总分及各项目评分均高于对照组(P<0.05)。研究组干预后癌因性评分低于对照组,组间差异明显(P<0.05)。且研究组干预后生活质量各维度评分高于对照组,研究组护理满意度为96.00%,与对照组的80.00%比较明显较高,P<0.05,差异有统计学意义。结论分化型甲状腺癌术后~(131)I治疗患者中应用协同护理模式,能够有效改善患者心理状况,减轻患者癌因性疲乏,增强患者自我效能感,从而提升患者自护能力,改善患者生活质量及满意度,在临床具有较高的应用价值。  相似文献   

7.
目的:探讨辛伐他汀治疗脂肪肝的的临床疗效。方法:120例脂肪肝患者随机分为两组,辛伐他汀治疗组60例采用辛伐他汀20mg,每天1次口服;血脂康治疗组60例采用血脂康600mg,每天2次口服。8周为1个疗程,共3个疗程,观察辛伐他汀治疗组与血脂康治疗组的临床疗效、治疗前后血脂和B超变化情况,另选择同期体检证明为正常的健康者70人作为对照组。结果:辛伐他汀治疗组总有效率(93.1%)与血脂康组(90.3%)相似(P>0.05);辛伐他汀治疗组和血脂康治疗组治疗后与治疗前相比血总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白(HDL-C)均明显改善(P<0.01),辛伐他汀治疗组改善优于血脂康组(P<0.05或P<0.01),辛伐他汀治疗组与血脂康治疗组两组治疗后肝功能与治疗前相比均明显改善(P<0.01),但辛伐他汀治疗组与血脂康治疗组两组治疗后相比无显著差异(P>0.05),未见严重不良反应。结论:辛伐他汀是治疗高血脂和脂肪肝的有效药物之一,且副作用少,安全性大,值得临床应用。  相似文献   

8.
Objective: To evaluate the benefit of intraoperative ERCP and endoscopic sphincterotomy (EST) combined with laparoscopic cholecystectomy (LC) in the treatment of cholelithiasis with choledocholithiasis. Methods: Fifty-two patients with cholelithiasis and choledocholithiasis (as determined by intraoperative cholangiography) were randomly divided into 2 groups during LC. In group A (27 patients), common bile duct stones were extracted by intraoperative EST during LC. In group B(25 patients), common bile duct (CBD) stones were extracted by conversion to open CBD exploration and cholecyctectomy. Results: The success rate was 26/27 (96.3%) in group A and 25/25 (100%) in group B (0.25<P<0.5); The mean postoperative hospitalization was 3.32±0.56 days in group A and 17.5±4.61 days in group B (P<0.001). In group A, two cases were complicated transient hyperamylasemia after the combined procedure. In group B, one case of bile leakage and one case of duodenal ulcer occurred after conversion to open cholecystectomy with CBD exploration. There were no retained stones in group A but 2 cases in group B. Conclusion: Intraoperative ERCP and endoscopic sphincterotomy combined with LC for treatment of cholelithiasis and chiledochlithiasis is safe, effective and results in shorter hospitalization and fewer complications than traditional open cholecystectomy with CBD exploration.  相似文献   

9.
血清镍铬元素含量检测用于镍铬合金烤瓷冠修复的研究   总被引:12,自引:0,他引:12  
目的:研究镍铬合金烤瓷冠修复后血清中镍铬元素含量的变化,探讨镍铬合金长期存在于口腔中的安全性。方法:选取60名经体检合格且无任何病史的健康人作为正常对照组,采用石墨炉原子吸收光谱法测得其血清中镍铬元素含量;再从我院修复科选取60名上、下颌前牙有任意三颗行镍铬合金烤瓷冠修复后半年和一年的血清中镍铬元素含量作为实验组,并对实验组和对照组的镍铬元素含量进行分析。结果:血清镍含量:实验半年组与对照组比较无显著性差异(P〉0.05);实验一年组与对照组相比较有显著性差异(P〈0.05);实验一年组与半年组比较无显著性差异(P〉0.05)。血清铬含量:各组之间比较均无显著性差异(P〉0.05)。结论:镍铬合金烤瓷冠修复后会在口腔环境中释放一定的镍和铬,但量很微小,远低于对人体产生毒副作用的水平。  相似文献   

10.
目的:观察镍铬合金烤瓷冠修复后头发和血液中镍铬元素含量的变化,探讨镍铬合金长期存在于口腔中的安全性。方法:选取60名经体检合格的健康人作为正常对照组;60名上、下颌前牙有任意三颗行镍铬合金烤瓷冠修复的患者作为实验组。实验组修复后半年及一年和对照组均采用火焰原子吸收光谱法测定头发镍铬元素含量,采用石墨炉原子吸收光谱法测得其血清中镍铬元素含量。结果:头发镍含量:实验半年组与对照组比较无显著性差异(P>0.05);实验一年组与对照组相比较有显著性差异(P<0.05);实验一年组与半年组比较无显著性差异(P>0.05)。头发铬含量:各组之间比较均无显著性差异(P>0.05)。血清镍含量:实验半年组与对照组比较无显著性差异(P>0.05);实验一年组与对照组相比较有显著性差异(P<0.05);实验一年组与半年组比较无显著性差异(P>0.05)。血清铬含量:各组之间比较均无显著性差异(P>0.05)。结论:镍铬合金烤瓷冠修复后会在口腔环境中释放一定的镍、铬,且释放的量与时间有关,但量很微小,头发和血液中镍铬元素含量呈正相关。  相似文献   

11.
目的:探讨零缺陷护理模式对脑出血患者术后神经康复效果与生活质量的影响。方法:纳入赣州市人民医院2016年3月至2018年1月收治的、行手术治疗的100例脑出血患者作为研究对象,随机分为观察组(n=50)和对照组(n=50)。对照组采用心理疏导、健康宣教、切口护理、饮食指导等常规护理,观察组在对照组的基础上采用零缺陷护理模式。两组均干预1个月,收集并分析两组患者神经功能评分(NIHSS)、生活自理能力评分(FIM)及生活质量变化情况。结果:观察组干预后NIHSS评分低于对照组,差异具有统计学意义(P<0.05);观察组干预后FIM评分高于对照组,差异具有统计学意义(P<0.05);观察组一般健康状况、生活能力、生理职能、情感职能、躯体疼痛、生理机能、精神健康、社会功能评分均高于对照组,差异具有统计学意义(P<0.05)。结论:零缺陷护理模式能提高脑出血患者患者神经功能修复,提高患者日常生活活动能力,提高患者临床预后效果。  相似文献   

12.
INTRODUCTIONHypertensionisalwaysaccompaniedbyin creasesinarterywallthickness,mainlycausedbyproliferation ,hypertrophy ,migrationandap optosisofvascularsmoothmusclecells(VSMC) ,andelevatedcontentofconnectivetissue .Thesestructuralchangesinbloodvesselsarekn…  相似文献   

13.
This study was aimed to investigate the level of sEGF in CAG with different therapies of either Chinese traditional medicine or western medicine. Patients were divided into spleen-reinforcingⅠ, spleen-reinforcing Ⅱ,dampness-resolving and western medicine group by Differentiation Syndrome. Healthy volunteers acted as controls. The sEGF was investigated before and after treatment. The level of sEGF in CAG was higher than that in control group(P<0.01). In patients of spleen-reinforcingⅠgroup and spleen-reinforcing Ⅱgroup, the symptoms and pathological manifestations were improved dramatically (P<0.01) and sEGF dropped markedly after treatment(P<0.01 and P<0.05).The level of sEGF in the dampness-resolving group increased after treatment (P<0.05). But the level of sEGF in the western-medicine group dropped a little after treatment (P>0.05). The inflammation of gastric mucosa may cause the elevation of sEGF in CAG reflectively. After being effectively treated with Chinese traditional medicine, the symptoms of CAG improved simultaneously with the return of sEGF. SEGF is a sensitive index to prognosis of CAG.  相似文献   

14.
肝素治疗胎儿生长受限临床应用探讨   总被引:1,自引:0,他引:1  
目的:探讨肝素用于治疗胎儿生长受限(FGR)的临床疗效及安全性。方法:将74例胎儿生长受限患者随机分为3组,分别使用低分子右旋糖酐加复方丹参(对照组)、普通肝素(UFH)、低分子肝素(LMWH)治疗。治疗前、治疗后1周及终止妊娠前,行彩色超声检查,监测胎儿生长情况和脐血流变化,同时监测各项凝血指标,记录新生儿情况并进行随访。结果:(1)UFH组、LMWH组治疗后宫高、胎儿股骨长、头围、腹围增长值均高于对照组,差异有显著性(P<0.05),LMWH组胎儿双顶径增长显著高于对照组(P=0.031)。(2)两肝素组治疗后脐动脉收缩期最大血流速度(S)与舒张末期血流速度(D)的比值(S/D比值)、搏动指数(PI)、阻力指数(RI)与对照组比较均明显降低,差异有统计学意义(P<0.05),而两肝素组间比较无统计学差异(P>0.05)。(3)UFH组、LMWH组治疗后新生儿胎龄、出生体重、身长、胎盘重量均较对照组明显增加(P<0.05),而两肝素组间无显著差异(P>0.05);新生儿窒息、胎死宫内、新生儿死亡发生率、早产发生率和新生儿畸形发生情况各组间无统计学差异(P>0.05);对照组足月小样儿发生率明显高于两肝素组(P=0.005),而肝素组之间则无显著差异(P>0.05)。对照组与LMWH相比,新生儿转重症监护病房(NICU)几率明显升高(P=0.003)。(4)各组孕妇治疗前后各项凝血功能检测值比较,差异均无显著性(P>0.05),产后出血量及产后出血发生率相比差异亦无统计学意义。结论:肝素可改善胎盘血流,使胎儿体重增加,减少足月小样儿的发生率,且不增加产后出血发生机会,对母亲及胎儿都较安全。LWMH治疗FGR,新生儿转NICU几率明显低于对照组,效果优于普通肝素,且使用方便,产妇易于接受,更适于推广。  相似文献   

15.
Objective:Atherosclerotic plaques and neovascularization play an important role in the course of coronary atherosclerosis.This study evaluated the effect of recombinant endostatin on experimental atherosclerotic plaques and neovascularization in rabbits.Methods:Eighteen healthy male rabbits were divided into three groups:control group,atherosclerotic model group,and recombinant endostatin treated group.The atherosclerotic model was established via a high-cholesterol diet after balloon catheter injury.The subject weights,serum total cholesterol,creatine kinase-myocardial band fraction(CKMB),and matrix metalloproteinase-2(MMP-2)were measured.Six weeks after treatment,the aortic roots were taken for pathological assay.The thickness ratio of the intima to media was measured by hematoxylin and eosin(HE)staining,and the number of neovessels was measured by immunohistochemistry via monoclonal antibody CD31 staining.Results:The weight,plasma total cholesterol,and CKMB were not significantly different between the atherosclerotic model group and the recombinant endostatin treated group,but much higher than those of the control group(P<0.05).The thickness ratio of the intima to media in the recombinant endostatin treated group was distinctly less than that in the atherosclerotic model group(P<0.05).The number of neovessels decreased dramatically(P<0.05)and the content of MMP-2 decreased slightly without statistical difference(P>0.05)in the recombinant endostatin treated group,compared to the atherosclerotic model group.Conclusions:Recombinant endostatin is able to inhibit the growth of neovascularization in the atherosclerotic plaque and the development of plaque.  相似文献   

16.
Objective: To explore the effects of cytomegalovirus (CMV) infection on rejection-related gene expression in the endothelial cells of renal transplantation recipients. Methods: Endothelial cells (ECs) were cultured and stimulated by a variety of factors: A, normal control group; B, inactivated human cytomegalovirus (HCMV) infection group; C, HCMV infection group; D, HCMV supematant infection group; and E, ganciclovir HCMV group. Expression of intercellular adhesion molecule-1 (ICAM-1) and major histocompability complex (MHC) class Ⅰ and class Ⅱ antigens was detected by flow cytometry (FCM) and immuno-histochemistry. Results: We found characteristic CMV-infected ECs in this study. There were no significant differences among groups A, B and D (P>0.05). Although the expression levels of ICAM-1 were not significantly different between groups C and E (P>0.05), the ICAM-1 expression in these two groups was significantly higher than that in group A (P<0.05). ICAM-1 expression was detected in groups C and E, while there was no expression in groups A, B and D. Furthermore, there was no significant difference of ICAM-1 mRNA expression between groups C and E (P>0.05). Human leucocyte antigen (HLA)-ABC expression was detected in all the groups, while HLA-DR expression was only detected in groups C and E. There were no significant dif-ferences of HLA-ABC and HLA-DR expression among groups A, B and D (P>0.05). However, the HLA-ABC and HLA-DR expression levels in groups C and D were higher than those of the remaining groups previously reported (P<0.05). Meanwhile, the HLA-ABC and HLA-DR expression levels in group E were lower than those of group C (P<0.05). Conclusion: CMV could up-regulate the expression levels of ICAM-1 and MHC antigens, which was closely related to allograft rejection.  相似文献   

17.
目的:探讨舍曲林合并舒必利治疗精神分裂症的疗效和安全性.方法:将60例符合CCMD-3诊断标准的精神分裂症患者随机分为研究组和对照组,研究组给予舍曲林合并舒必利治疗,对照组服用阿立哌唑,疗程8周,用PANSS、TESS评定疗效和安全性.结果:研究结束时舍曲林合并舒必利组总有效率为86.7%,阿立哌唑组总有效率83.3%,两组比较无显著性差异(P>0.05).两组不良反应少且轻.结论:采用舍曲林合并舒必利的方法治疗精神分裂症疗效可靠,安全性好,值得进一步研究.  相似文献   

18.
胃肠道癌术后化疗T细胞亚群和sIL-2R的比较研究   总被引:2,自引:0,他引:2  
目的:比较化疗前后T细胞亚群和sIL-2R水平及术后腹腔化疗和静脉化疗T细胞亚群和sIL-2R水平有无差异。方法:54例胃肠道癌症患者,分两组27例,一组接受腹腔化疗,另一组接受静脉化疗,检测血清中T细胞亚群和sIL-2R水平。结果:化疗后血清CD3、CD4和sIL-2R水平较化疗前明显下降(P<0.01)。CD3、CD4、CD8在两治疗组之间相似(P>0.01),但sIL-2R水平腹腔化疗低(0.05P相似文献   

19.
1日龄AA肉鸡160只,随机分成4组。1~4组饮水中肌肽添加剂量分别为0(对照组)、20(低剂量组)、40(中剂量组)、60(高剂量组)mg/L,试验期6周。于2、4、6周末每组随机取6只肉鸡心脏采血,测定血清中的谷丙转氨酶(ALT)、谷草转氨酶(AST)活力和总胆固醇(TC)的含量。结果表明:肌肽各剂量组ALT活力在2、4、6周龄时均低于对照组,但组间差异均不显著(P>0.05)。4周龄时各剂量组AST的活力均高于对照组,2、6周龄均低于对照组(P<0.05或P<0.01)。生长中期肌肽组血清胆固醇含量有所上升,生长后期略微下降,肌肽对肝脏功能没有明显的影响。  相似文献   

20.
目的:探讨两种不同方式的健康教育对老年糖尿病患者治疗依从性及生活质量的影响。方法:将100例住院老年糖尿病患者随机分为集中健康教育组和个人健康教育组,分别给予集中健康教育和个体化健康教育,利用依从性调查表、生活质量量表和生化检测分别观察健康教育前后两组患者依从性、生活质量和治疗效果的变化。结果:健康教育前,两组患者依从性和生活质量及生化指标均无显著性差异,两组患者实施健康教育后,依从性、生活质量显著提高,且个体化健康教育效果明显优于集中健康教育(P<0.01)。结论:个体化健康教育能有效的提高老年糖尿病患者依从性和生活质量,更为有效地帮助老年糖尿病患者达到控制疾病的目的。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号